We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

354 hedge funds and large institutions have $6.43B invested in Bio-Rad Laboratories Class A in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 148 increasing their positions, 97 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 29

53% more repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 97

10% more capital invested

Capital invested by funds: $5.87B → $6.43B (+$562M)

7% more funds holding

Funds holding: 330 → 354 (+24)

2.26% more ownership

Funds ownership: 75.91% → 78.17% (+2.3%)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

69% less call options, than puts

Call options by funds: $9.75M | Put options by funds: $31.4M

Holders
354
Holders Change
+24
Holders Change %
+7.27%
% of All Funds
7.76%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.15%
New
54
Increased
148
Reduced
97
Closed
29
Calls
$9.75M
Puts
$31.4M
Net Calls
-$21.7M
Net Calls Change
-$37.2M

Top Buyers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$121M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$96.4M
3
BlackRock
BlackRock
New York
+$48.4M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$37M
5
Citadel Advisors
Citadel Advisors
Florida
+$34.7M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$120M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$61.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$47.9M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$28.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIL
376
AGF Investments LLC
Ontario, Canada
– -$9K -30 Closed
CWA
377
Clarus Wealth Advisors
Arizona
– -$5K -15 Closed
SIM
378
Sonora Investment Management
Arizona
– -$3K -11 Closed
CAW
379
Cornerstone Advisors (Washington)
Washington
– -$3K -10 Closed
TPWA
380
TRUE Private Wealth Advisors
Oregon
– -$2K -8 Closed
BL
381
Balentine LLC
Georgia
– -$2K -6 Closed
CFA
382
Camarda Financial Advisors
Florida
– -$1K -2 Closed
PWP
383
Personal Wealth Partners
Minnesota
– +$326 +1 New
12 13 14 15
16

BIO Hedge Fund Activity: Q3 2019 in Review

354 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2019, worth a combined $6.43B — up 9.6% from $5.87B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new BIO positions and 29 closed out — a net gain of 25 holders — while 148 added to existing stakes and 97 trimmed.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $121M. The largest seller was Easterly Investment Partners, cutting an estimated $120M.

  • 354 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2019, up from 330 in Q2 2019.
  • Funds reported $6.43B of Bio-Rad Laboratories Class A stock for Q3 2019, up 9.6% quarter-over-quarter.
  • 54 funds opened new Bio-Rad Laboratories Class A positions in Q3 2019 and 29 closed out, a net change of +25 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2019 was Acadian Asset Management, an estimated $121M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2019 was Easterly Investment Partners, an estimated $120M sold.

Based on aggregated 13F filings for Q3 2019.